CA-CYOLO
4.3.2024 14:31:29 CET | Business Wire | Press release
Cyolo, the access company for the digital enterprise, today announced the launch of Cyolo PRO (Privileged Remote Operations), a hybrid secure remote access solution for Operational Technology (OT). Developed specifically to enable safe operations of privileged users, Cyolo PRO is an advanced solution set to redefine Secure Remote Access (SRA) by shifting from managing access to managing operations. Aligning with the core principles of Remote Privileged Access Management (RPAM), Cyolo streamlines access processes providing a hybrid, infrastructure-agnostic solution with a low cost of change. Get Complimentary access to Gartner® report, Securing Remote Privileged Access Management Through RPAM Tools.
"As OT environments change, Cyolo PRO offers a comprehensive set of capabilities tailored to the unique, dynamic needs of organizations operating within these ecosystems. We have been attuned to the requirements emerging from the field, which has driven us to craft a secure, agile, and user-friendly tool,” said Almog Apirion, CEO & Co-founder at Cyolo. “This solution empowers organizations to seamlessly handle remote operations in their core units, without compromising productivity or security."
Cyolo PRO works across environments whether those are cloud-based, cloud-averse or offline. Key features of Cyolo PRO include:
- VPN-less Connectivity with Zero Trust Principles: Cyolo PRO introduces VPN-less connectivity, eliminating the risks associated with network access while adhering to Zero Trust principles.
- Identity Authentication and MFA for Legacy Apps: The solution ensures robust identity authentication, verifying the identity (instead of user) behind the access, even for legacy applications, enhancing overall security measures.
- Granular Access and Actions Management: Cyolo PRO offers granular control over access and actions management using the principles of “least privilege”, providing organizations with a flexible and secure framework.
- Massive Supervision Capabilities: The product includes extensive supervision features and Just in Time access, allowing organizations to monitor and manage remote access effectively.
“Our company has benefited a great deal from Cyolo’s platform,” said Gibson Mark, Senior Systems Administrator at Tata Chemicals. “We’re able to provide seamless remote access to our systems to both internal users and external users. The management overhead of these remote access connections has been greatly reduced. The ease of use of the remote access has been increased for third-party individuals and our internal employees. The adoption rates of these secure remote access methods have gone up substantially since we implemented Cyolo.”
Cyolo PRO is designed to answer the increasing security concerns and complexity around secure remote access in OT environments. Through its solution, Cyolo is empowering organizations with safe, secure and productive remote operations, even in the most demanding mission-critical settings. Its unique capabilities allow organizations to secure access to both internal and third-party users, operating online or offline and in hybrid, on-prem or cloud environments. This comprehensive suite also ensures industry compliance and guarantees uptime, safety and operational integrity.
“With Cyolo PRO’s features, tailored specifically for OT ecosystems, Cyolo is positioning itself as a market leader,” said Joe O’Donnell, Executive Vice President of Corporate Development at Cyolo. “The solution’s capability to seamlessly fit into existing architectures without extensive change management processes is critical in OT environments, as even the slightest change can yield significant consequences.”
Cyolo PRO is now available for enterprises across all critical industries, including manufacturing, oil & gas, utilities, pharmaceuticals, transportation and more. Consolidate your security stack and experience the power of seamless and secure operations across any application in any environment, from legacy infrastructure to cloud environments. Visit https://cyolo.io/ to learn more.
Gartner, Securing Remote Privileged Access Management Through RPAM Tools, Abhyuday Data, Felix Gaehtgens, Michael Kelley, 28 December 2023.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About Cyolo
Cyolo is a leading cybersecurity innovator dedicated to providing cutting-edge access solutions for all environments and deployment scenarios. With a focus on security, operational agility, and user experience, Cyolo is fostering a transition from merely enabling access to empowering operations, productivity, and compliance with its Cyolo PRO (Privileged Remote Operations) solution.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240304157756/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million
IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p
HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release
HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha
Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char
DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors27.2.2026 08:18:00 CET | Press release
Will accelerate the development and mass production of EUV lithography photomasks Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) today announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027. Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors. Background In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption. Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
